[go: up one dir, main page]

DK0542802T3 - Stimulering af hårvækst med kaliumkanalåbnere og 5alfa-reduktase-inhibitorer - Google Patents

Stimulering af hårvækst med kaliumkanalåbnere og 5alfa-reduktase-inhibitorer

Info

Publication number
DK0542802T3
DK0542802T3 DK91913987.3T DK91913987T DK0542802T3 DK 0542802 T3 DK0542802 T3 DK 0542802T3 DK 91913987 T DK91913987 T DK 91913987T DK 0542802 T3 DK0542802 T3 DK 0542802T3
Authority
DK
Denmark
Prior art keywords
potassium channel
hair growth
alpha
reductase inhibitors
stimulation
Prior art date
Application number
DK91913987.3T
Other languages
Danish (da)
English (en)
Inventor
Heinrich Josef Schostarez
Arthur Robert Diani
Allen Edwin Buhl
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0542802T3 publication Critical patent/DK0542802T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91913987.3T 1990-08-10 1991-07-29 Stimulering af hårvækst med kaliumkanalåbnere og 5alfa-reduktase-inhibitorer DK0542802T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56577790A 1990-08-10 1990-08-10

Publications (1)

Publication Number Publication Date
DK0542802T3 true DK0542802T3 (da) 1996-07-22

Family

ID=24260045

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913987.3T DK0542802T3 (da) 1990-08-10 1991-07-29 Stimulering af hårvækst med kaliumkanalåbnere og 5alfa-reduktase-inhibitorer

Country Status (12)

Country Link
US (1) US5578599A (fr)
EP (1) EP0542802B1 (fr)
JP (1) JP3004718B2 (fr)
KR (1) KR100192734B1 (fr)
AT (1) ATE134877T1 (fr)
AU (1) AU646069B2 (fr)
CA (1) CA2085605C (fr)
DE (1) DE69117762T2 (fr)
DK (1) DK0542802T3 (fr)
ES (1) ES2084175T3 (fr)
GR (1) GR3019789T3 (fr)
WO (1) WO1992002225A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516768A (en) * 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
GB2274060A (en) * 1993-01-07 1994-07-13 Merck & Co Inc Treatment of patterned alopecia with 17ß-acyl-4-aza-5-androst-1-ene-3-ones and minoxidil
AU6083494A (en) * 1993-01-07 1994-08-15 Merck & Co., Inc. Combination method for treating patterned alopecia with 17beta -n-substituted-carbamoyl-4-aza-5alpha-androst-1-en-3- ones and minoxidil
US5407944A (en) * 1993-02-19 1995-04-18 Goldman; Boris E. Compositions and methods for promoting hair growth
ATE158301T1 (de) * 1993-06-28 1997-10-15 Merck & Co Inc 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
US5547957A (en) 1993-10-15 1996-08-20 Merck & Co., Inc. Method of treating androgenic alopecia with 5-α reductase inhibitors
WO1995013815A1 (fr) * 1993-11-18 1995-05-26 Merck & Co., Inc. Procede combine pour le traitement de l'alopecie hippocratique
FR2717381B1 (fr) * 1994-03-15 1996-04-19 Oreal Compositions à base d'alpha-pyrones pour induire et stimuler la croissance des cheveux et/ou freiner leur chute et utilisation.
US5886005A (en) * 1995-01-17 1999-03-23 Merck & Co., Inc. 4-Aza-19-norandrostane derivatives
EP0862436A1 (fr) * 1995-10-19 1998-09-09 Merck & Co., Inc. Inhibiteurs de 5-alpha-reductase a 6-aza-steroides a substitution en position 16
JPH10203933A (ja) * 1997-01-27 1998-08-04 Kao Corp 養毛・育毛料
US6013668A (en) 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US20050153940A1 (en) * 2000-01-26 2005-07-14 Cedars-Sinai Medical Center Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
US7018979B1 (en) 2000-01-26 2006-03-28 Cedars-Sinai Medical Center Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
KR20020005332A (ko) * 2000-07-10 2002-01-17 정상훈 탈모증 치료용 키트
DE10036799A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Neues Mittel zur Behandlung der Haare und der Kopfhaut
SE0100374D0 (sv) * 2001-02-07 2001-02-07 Pharmacia Ab Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
RU2181584C1 (ru) * 2001-04-25 2002-04-27 Московская медицинская академия им. И.М. Сеченова Стимулятор роста волос
US7211561B2 (en) * 2001-10-12 2007-05-01 Cedars-Sinai Medical Center Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
SE0104421D0 (sv) * 2001-12-21 2001-12-21 Ponsus Pharma Ab New composition
EP1850852A4 (fr) * 2005-02-22 2009-11-18 Cedars Sinai Medical Center Utilisation du sildenafil, du vardenafil et d'autres inhibiteurs de la 5-phosphodiesterase pour augmenter la permeabilite d'une barriere sang /cerveau anormale
US7914548B2 (en) * 2006-04-17 2011-03-29 Ustuner E Tuncay Prevention or treatment of male pattern baldness method and device
EP2343061A1 (fr) 2009-12-28 2011-07-13 Lipofoods, S.L. Utilisation d'extrait d'huile de pin et compositions le contenant
KR101205209B1 (ko) * 2011-04-25 2012-11-27 박준형 탈모방지 및 발모촉진용 외용제 조성물
WO2015155609A2 (fr) * 2014-04-11 2015-10-15 Bcs Business Consulting Services Pte Ltd Composition d'embellissement des sourcils et des cils
MX390288B (es) * 2018-02-06 2025-03-20 Centro Int De Cosmiatria S A P I De C V Formulación y método para el tratamiento de la alopecia androgénica.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4596812A (en) * 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
DE3486090T2 (de) * 1983-12-12 1993-08-05 Kaszynski Edwin G Haarwuchsmodifikation.
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens
EP0232311B1 (fr) * 1985-07-18 1993-05-12 PROCTOR, Peter H. Composition topique et procede destines a stimuler la croissance des cheveux
DE3615396A1 (de) * 1986-05-07 1987-11-12 Wella Ag Mittel zur behandlung der haare und der kopfhaut
US5026691A (en) * 1987-03-30 1991-06-25 The Upjohn Company Combination of minoxidil and an antiinflammatory agent for treating patterned alopecia
WO1988007361A1 (fr) * 1987-03-30 1988-10-06 The Upjohn Company Combinaison de minoxydil et d'un agent anti-inflammatoire pour le traitement de l'alopecie typique des personnes de sexe masculin
EP0285382B1 (fr) * 1987-04-03 1994-04-13 Merck & Co. Inc. Traitement d'alopécia androgénique avec 17-bêta-n-monosubstitué-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones
JPH01305017A (ja) * 1988-05-31 1989-12-08 Yakurigaku Chuo Kenkyusho:Kk 脱毛症治療剤
WO1990006100A1 (fr) * 1988-12-02 1990-06-14 The Upjohn Company Compositions a base de minoxidil et de substances vasoconstrictives pour le traitement de l'alopecie

Also Published As

Publication number Publication date
AU646069B2 (en) 1994-02-03
EP0542802A1 (fr) 1993-05-26
US5578599A (en) 1996-11-26
AU8301091A (en) 1992-03-02
EP0542802B1 (fr) 1996-03-06
CA2085605A1 (fr) 1992-02-11
WO1992002225A1 (fr) 1992-02-20
KR100192734B1 (ko) 1999-06-15
DE69117762D1 (de) 1996-04-11
ATE134877T1 (de) 1996-03-15
DE69117762T2 (de) 1996-08-08
ES2084175T3 (es) 1996-05-01
JP3004718B2 (ja) 2000-01-31
GR3019789T3 (en) 1996-07-31
CA2085605C (fr) 2003-03-11
JPH06500081A (ja) 1994-01-06

Similar Documents

Publication Publication Date Title
DK0542802T3 (da) Stimulering af hårvækst med kaliumkanalåbnere og 5alfa-reduktase-inhibitorer
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
HU9204093D0 (en) Method and preparative for treatment of fall of hair and baldness
BR9814374B1 (pt) "urÉias heterocÍclicas substituÍdas e composiÇÕes compreendendo as mesmas"
DE69630214D1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
PL336842A1 (en) Compositions for oxidisingly dyeing creatine fibre, containing an azo derivative of 3-amino- pyridine and method of dyeing using that composition
MD1616G2 (ro) Compuşi triciclici şi metodă de inhibare a receptorului tirozin kinazei pentru factorul de creştere epidermic, compoziţie farmaceutică, metode de prevenire a implantării blastocitului şi tratament al mamiferelor
DE69230347D1 (de) Adenosinkinaseinhibitoren
MD1632G2 (ro) Compuşi biciclici, metodă de inhibare a receptorulor tirozinkinazei pentru factorul de creştere epidermic, compoziţie farmaceutică, metode de prevenire a implantării blastocitelor şi de tratament al mamiferelor
DK0728462T3 (da) Kosmetisk fremgangsmåde og præparat til behanling af hårtab
IL128691A0 (en) Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
BG100510A (en) Method of treating androgenic alopecia with 5-alpha reductase inhibitors
ATE120190T1 (de) 5-fluor-2,4,6-pyrimidinthiaminderivate zur verhinderung des haarsausfalls.
IS3909A (is) Efnablanda til örvunar hárvaxtar
PH31673A (en) Method of preventing and treating chemotherapy-induced alopecia.
DK1076561T3 (da) Kombinationsterapi til behandlingen af tumorer
NO990436D0 (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DK100785D0 (da) Midler til stimulering af haarvaekst